Auxilium Testim
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Auxilium's male hormone replacement therapy Testim (testosterone gel) clears FDA Oct. 31 for treatment of hypogonadism. The Testim clinical trials, involving 644 hypogonadal men, were the largest ever conducted in testosterone replacement therapy, Auxilium said. The gel uses Bentley's CPE-215 drug delivery technology, which is licensed to Auxilium. Testim is Auxilium's first commercial produc